Physician
Tennessee Retina PC
Tennessee Retina PC was paid $5.97M by Medicaid between Jan 2018 and Dec 2024, across 14 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 40% of everything it billed.
33Billing provider infoTENNESSEE RETINA PC
NASHVILLE, TN 37203
NASHVILLE, TN 37203
33aNPI1497828321assigned 11/16/2006
33bProvider typeOphthalmology Physician
28Total paid$5.97M
24GClaims165,913
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Tennessee
Rank by total paid#1 of 114
Median peer was paid$15K
This provider vs. median406×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,000 | $565K | |
| 2019 | 24,206 | $592K | |
| 2020 | 22,224 | $580K | |
| 2021 | 27,591 | $773K | |
| 2022 | 25,829 | $705K | |
| 2023 | 24,704 | $1.46M | |
| 2024incomplete | 18,359 | $1.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 40% | 39,405 | 28,482 | $2.39M |
| J0178 | Injection, aflibercept, 1 mg | 21% | 2,488 | 1,477 | $1.22M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 12% | 32,561 | 24,928 | $721K |
| J9035 | Injection, bevacizumab, 10 mg | 10% | 29,522 | 16,934 | $608K |
| 92134 | 8.3% | 49,209 | 36,600 | $493K | |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3.7% | 1,290 | 720 | $221K |
| 92250 | 3.1% | 8,784 | 7,186 | $188K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 2,062 | 1,694 | $109K |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | <1% | 43 | 13 | $6K |
| 99223 | Prolong inpt eval add15 m | <1% | 43 | 38 | $5K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | <1% | 38 | 26 | $3K |
| 92235 | <1% | 78 | 60 | $3K |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAWH, CARL (DOCTOR)